26 Conflict of Interest Statement Esempi: Advisory boards, consulting fees, research grants, speakers bureau, economical support for meeting organization. Aziende Farmaceutiche/ Diagnostiche Relazione Francesca Ceccherini Silberstein 1-Abbott, 2-Bristol Myers Squibb, 3-Gilead Sciences, 4-Janssen Cilag, 5-MSD, 6-ViiV, 7-Roche Advisory boards: 6 Consulting fees: 3,5,6 Research grants: 5,7 Speakers bureau/lectures: 1,2,3,4,5,6,7 Economical support for meeting organization: 1,5,6 Alessia Ciancio 1-Roche, 2-MSD, 3-Bristol Myers Squibb, 4-Gilead Sciences, 5-Janssen Cilag, 6-AbbVie Advisory board: 4, 6 Speakers bureau: 1,2,3,4,5,6 Marco Marzioni Nessuna Nessuna Maria Rendina 1-Roche, 2-MSD, 3-Bristol Myers Squibb, 4-Gilead Sciences, 5-Biotest Italia, 6-Kedrion, 7-Grifols Italia Advisory board: 1, 2, 6 Speakers bureau: 1,2,3,4,5,6,7 Consulting fees: 6,7 Marco Senzolo Novartis, Astellas, Biotest, Alexion Economical support in meeting organization Nessuna Nessuna AbbVie, GileadSciences, Janssen Cilag Advisory Board AbbVie, GileadSciences, MSD, Janssen Cilag Speaker Bureau Davide Bitetto Nessuna Nessuna Raffaele Bruno AbbVie, Boehringer Ingelheim, Gilead Sciences, Janssen Cilag, MSD, Roche He acted as an advisor and/or lecturer Salvatore Petta AbbVie, Janssen Cilag, MSD Advisory boards, consulting fees Novartis Farma Research grant AbbVie, Gilead Sciences, Janssen Cilag, MSD, Novartis Farma, Roche AbbVie, Bristol Myers Squibb, Gilead Sciences, MSD, Novartis Farma, Janssen Cilag, Roche Janssen Cilag Roche AbbVie Gilead Sciences MSD Bristol Myers Squibb Boehringer Ingelheim Abbott, AbbVie, Bristol Myers Squibb, Fujirebio, Gilead Sciences, Janssen Cilag, MSD, Roche Abbott, Bristol Myers Squibb, Gilead Sciences, Janssen Cilag, MSD, Novartis Farma, Roche Speakers Bureau Estensore/Revisore Luca Valenti Alessio Aghemo Pierluigi Toniutto Alfredo Alberti Pietro Andreone Ferruccio Bonino Maurizia Rossana Brunetto Linee di indirizzo AISF – HCV, Giugno 2014 Advisory board, speakers bureau, research grants, support for sponsored meetings Advisory board, speakers bureau Advisory board, speakers bureau Advisory board Advisory board, speakers bureau Advisory board, speakers bureau Consulting fee, speakers bureau Advisory board Advisory boards, speakers bureau and economical support for meeting organization Speakers' Bureau 27 Estensore/Revisore Savino Bruno Nicola Caporaso Paolo Caraceni Massimo Colombo Antonio Craxì Giovanni Battista Gaeta Massimo Levrero Alessandra Mangia Massimo Puoti Giovanni Raimondo Mario Rizzetto Mariagrazia Rumi Linee di indirizzo AISF – HCV, Giugno 2014 Aziende Farmaceutiche/ Diagnostiche AbbVie, Bristol Myers Squibb, Gilead Sciences, MSD Relazione Advisory boards AbbVie, MSD Speakers bureau AbbVie, Bayer, Bristol Myers Squibb, Gilead Sciences, MSD, Roche AbbVie, Boehringer Ingelheim, Gilead Sciences, MSD Economical support for meeting organization Advisory boards Gilead Sciences, Roche Research grants Bristol Myers Squibb, Gilead Sciences, MSD, Janssen Cilag, Roche Speaker Nessuna Nessuna MSD, Roche, Bristol Myers Squibb, Gilead Sciences Grant and research support Merck, Roche, Novartis, Bayer, Bristol Myers Squibb, Gilead Sciences, Tibotec, Vertex, Janssen Cilag, Achillion, Lundbeck, Abbott, Boehringer Ingelheim, GlaxoSmithKline, GenSpera, AbbVie Advisory committees Tibotec, Roche, Novartis Farma, Bayer, Bristol Myers Squibb, Gilead Sciences, Vertex AbbVie,Achillion, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Gilead Sciences, Inframed, Janssen Cilag, MSD, Novartis Farma, Roche, Vertex Janssen Cilag, MSD, AbbVie, Gilead Sciences, Bristol Myers Squibb Bristol Myers Squibb Gilead Sciences MSD Janssen Cilag Roche AbbVie, Bristol Myers Squibb Gilead Sciences, Janssen Cilag, MSD, Roche AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Janssen Cilag, MSD, Novartis Farma, Gilead Sciences, Roche AbbVie, Bristol Myers Squibb, Gilead Sciences, Janssen Cilag, MSD, Roche AbbVie, Bristol Myers Squibb, Janssen Cilag, MSD Janssen Cilag, Roche Speaking and teaching Advisory boards, consultancy, lecture fees, clinical trials advisor ship and participation over the last two years Speaker and/or Advisor Speaker, Meeting support Advisory, Speaker, Meeting support Speaker, Meeting support Advisory, Speaker, Meeting support Speaker, Meeting support Speaker / Advisory / Research founding Advisory Boards, Docente in corsi per personaleInterno, Grant per ricerca, Speaker in own events Advisory boards/Speaker bureau Advisory Board Advisory Board Bristol Myers Squibb, Gilead Sciences, MSD, Roche Speaker fees AbbVie, MSD, Roche Travel grant 28 Estensore/Revisore Gloria Taliani Erica Villa Anna Linda Zignego Linee di indirizzo AISF – HCV, Giugno 2014 Aziende Farmaceutiche/ Diagnostiche AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Gilead Sciences, Janssen Cilag, MSD, Novartis Farma, Roche 1-Roche, 2-MSD, 3-Bristol Myers Squibb, 4-Gilead Sciences, 5-AbbVie, 6-GSK, 7- Novartis Farma Bristol Myers Squibb, Gilead Sciences, Janssen-Cilag, MSD, Roche Relazione Speaking, Teaching, Advisory Board Unrestricted research grant: 1, 2 Advisory Board: 2,5,6 Speakers Bureau: 2,3,4,5,6,7 Economical support for meeting organization, advisory boards, consulting fees, participation to mono-sponsor meetings
© Copyright 2024 Paperzz
